Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
    Datensatz exportieren als...
  • BibTeX
P5-10-01: Metabolic Pharmacodynamic Effect Evidenced by 18FDG-PET as a Tool for Early Prediction of Iniparib Efficacy in Metastatic Triple Negative Breast Cancer (MTNBC): A Proof of Concept Study
Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P5-P5-10-01
2011
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P6-07-28: The 21-gene assay in the decision impact assessment of ER+, HER2- Breast cancer: A French real life prospective study
Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P6-P6-07-28
2017
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P5-15-06: Impact of post-progression therapy on overall survival (OS) in the IMELDA randomized phase III trial evaluating the addition of capecitabine (CAP) to maintenance bevacizumab (BEV) for HER2-negative metastatic breast cancer (mBC)
Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P5-P5-15-06
2017
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract OT1-03-01: Chemotherapy-free trastuzumab and pertuzumab in HER2 [+] breast cancer: FDG-PET response-adapted strategy. The PHERGain study
Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.OT1-03-01-OT1-03-01
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P6-07-05: Interactions between adipocyte stem cells and normal or tumoral mammary epithelial cells. Potantial role of BRCA status and estrogen pathway
Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P6-P6-07-05
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract OT1-01-01: IMpassion131: A phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (TNBC)
Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.OT1-01-01-OT1-01-01
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P1-13-09: Prognostic relevance of prior endocrine treatments in overall survival (OS) at the time of first line chemotherapy in ER[+]/HER2[-] advanced breast cancer (ABC) patients
Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P1-P1-13-09
2016
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract OT1-02-03: Phase I multicenter clinical trial evaluating the combination of trastuzumab emtansine (T-DM1) and non-pegylated liposomal doxorubicin (NPLD) in HER2-positive metastatic breast cancer (MBC) (MEDOPP038 study)
Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.OT1-02-03-OT1-02-03
2017
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract GS3-07: Clinical utility of circulating tumor cell count as a tool to chose between first line hormone therapy and chemotherapy for ER+ HER2- metastatic breast cancer: Results of the phase III STIC CTC trial
Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.GS3-07-GS3-07
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P2-16-06: Influence of trastuzumab pre-exposure in non metastatic disease to first line metastatic treatment efficacy including trastuzumab: The University Cancer Center - University Pierre & Marie Curie (IUC-UPMC) experience
Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P2-P2-16-06
2013
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P4-12-08: Final efficacy results from a single-arm multicenter phase II study evaluating first-line trastuzumab, bevacizumab, and capecitabine (HAX) therapy for HER2-positive locally recurrent/metastatic breast cancer (LR/mBC)
Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P4-P4-12-08
2013
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P6-14-01: Final results of the TANIA randomized phase III trial of bevacizumab (BEV) after progression on 1st-line BEV therapy for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)
Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P6-P6-14-01
2016
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P4-12-11: Patient preference for subcutaneous trastuzumab via handheld syringe versus intravenous infusion in HER2-positive early breast cancer: Cohort 2 of the PrefHer study
Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P4-P4-12-11
2013
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P6-12-06: Three-year follow up results of a phase II study of neoadjuvant bevacizumab, chemotherapy, and trastuzumab in HER2-positive inflammatory breast cancer: BEVERLY2 study
Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P6-P6-12-06
2013
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P6-12-08: Serum biomarkers identification using quantitative proteomics in patients with HER2-positive inflammatory breast cancer receiving trastuzumab plus bevacizumab-based chemotherapy (BEVERLY 2 trial)
Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P6-P6-12-08
2013
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
OT3-01-04: TANIA: A Randomized Phase III Trial Evaluating Continued and Reintroduced Bevacizumab (BEV) in Patients Previously Treated with 1st-Line BEV for Locally Recurrent/Metastatic Breast Cancer (LR/mBC)
Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.OT3-01-04-OT3-01-04
2011
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
P3-14-11: Comparison of Two Nomograms To Predict Pathologic Complete Response to Neoadjuvant Chemotherapy – Evidence That HER2 Positive Tumors Need Specific Predictors
Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P3-P3-14-11
2011
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P2-06-23: A New Way To Determine Multifocality: The Use of Molecular Markers?
Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P2-P2-06-23
2010
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Breast conservation in the treatment of T2 breast tumors – analysis of 1988-2003 SEER data
Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.5151
2009
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P5-17-04: Management of Antiangiogenics' Renovascular Safety in breast cancer. Subgroup and intermediate results of the MARS Study
Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P5-P5-17-04
2012
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P3-15-06: Results of the MARS study on the management of antiangiogenics’ renovascular safety in breast cancer
Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P3-P3-15-06
2013
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P3-14-19: Panitumumab in combination with FEC 100 (5-fluorouracil, epirubicin, cyclophosphamide) followed by docetaxel for operable, triple negative breast cancer (TNBC): Patient outcome
Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P3-P3-14-19
2013
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P5-21-01: pT1a, bpN0M0 breast cancer: clinicopathological characteristics and their impact on treatment decision. Central review of the prospective ODISSEE cohort
Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P5-P5-21-01
2012
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A Very Favourable Mammographic Screening Impact on Breast Cancer Characteristics and Treatment Modalities in France. Analysis of 2806 Cases
Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.4006-4006
2009
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
P2-12-06: Nomogram To Predict Subsequent Bone Metastasis in Patients with Non Metastatic Breast Carcinomas
Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P2-P2-12-06
2011
Volltextzugriff (PDF)
1 – 25 von 34
Suche als RSS-Feed
Aktive Filter
Zeitschrift / SerieCancer Research
Suchergebnisse filtern
Filter anzeigen
Nur zeigen
Publikationsform
Sprache
Erscheinungsjahr
n.n
n.n
Kollektion